ETVAX® was presented as the lead candidate at CISTM14

The International Society of Travel Medicine (ISTM) holds its leading worldwide scientific congress biennially. Approximately 2,000 delegates from over 50 countries is attending.

CISTM14 – 14th conference of the International Society of Travel Medicine has just been organized in Québec City, Canada. During the conference an up-to-date and broad-ranging program was presented by the key opinion leaders in the field. People from all over the world met and discussed travel related diseases.

Our ETEC vaccine Etvax® was of cause on the agenda. During a satellite symposium Richard Walker, from the American non-profit organization PATH Vaccine Solutions, described our vaccine project as the lead project when the “Advances in ETEC and Shigella prevention through vaccination” was presented.




Go to MyNewsdesk

We are a research-based specialty biopharma company determined to give people worldwide a longer and better life.